The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis

L.S. Spekhorst; M. de Graaf; L.P. van der Rijst; N.P.A. Zuithoff; R.C. Schweizer; M. Kamsteeg; I. Haeck; A.M.T. van Lynden-van Nes; P. van Lumig; G.L.E. Romeijn; M.L. Schuttelaar; M.S. de Bruin-Weller

doi:10.1002/clt2.12219

The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis

L.S. Spekhorst
, M. de Graaf
, L.P. van der Rijst^*
, N.P.A. Zuithoff
, R.C. Schweizer
, M. Kamsteeg
, I. Haeck
, A.M.T. van Lynden-van Nes
, P. van Lumig
, G.L.E. Romeijn
, M.L. Schuttelaar
, M.S. de Bruin-Weller

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Article number	e12219
Number of pages	4
Journal	Clinical and Translational Allergy
Volume	13
Issue number	1
DOIs	https://doi.org/10.1002/clt2.12219
Publication status	Published - 1 Jan 2023

Access to Document

10.1002/clt2.12219Licence: CC BY

Cite this

Spekhorst, L. S., de Graaf, M., van der Rijst, L. P., Zuithoff, N. P. A., Schweizer, R. C., Kamsteeg, M., Haeck, I., van Lynden-van Nes, A. M. T., van Lumig, P., Romeijn, G. L. E., Schuttelaar, M. L., & de Bruin-Weller, M. S. (2023). The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis. Clinical and Translational Allergy, 13(1), Article e12219. https://doi.org/10.1002/clt2.12219

@article{b2b190e4ac394c7ea77343e88a0fa2e9,

title = "The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis",

author = "L.S. Spekhorst and \{de Graaf\}, M. and \{van der Rijst\}, L.P. and N.P.A. Zuithoff and R.C. Schweizer and M. Kamsteeg and I. Haeck and \{van Lynden-van Nes\}, A.M.T. and \{van Lumig\}, P. and G.L.E. Romeijn and M.L. Schuttelaar and \{de Bruin-Weller\}, M.S.",

note = "Funding Information: Patients included in this manuscript participated in the BioDay registry sponsored by Sanofi-Regeneron, Abbvie, Eli Lilly and Company, Leo Pharma, and Pfizer.",

year = "2023",

month = jan,

day = "1",

doi = "10.1002/clt2.12219",

language = "English",

volume = "13",

journal = "Clinical and Translational Allergy",

issn = "2045-7022",

publisher = "John Wiley \& Sons Inc.",

number = "1",

}

Spekhorst, LS, de Graaf, M, van der Rijst, LP, Zuithoff, NPA, Schweizer, RC, Kamsteeg, M, Haeck, I, van Lynden-van Nes, AMT, van Lumig, P, Romeijn, GLE, Schuttelaar, ML & de Bruin-Weller, MS 2023, 'The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis', Clinical and Translational Allergy, vol. 13, no. 1, e12219. https://doi.org/10.1002/clt2.12219

TY - JOUR

T1 - The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis

AU - Spekhorst, L.S.

AU - de Graaf, M.

AU - van der Rijst, L.P.

AU - Zuithoff, N.P.A.

AU - Schweizer, R.C.

AU - Kamsteeg, M.

AU - Haeck, I.

AU - van Lynden-van Nes, A.M.T.

AU - van Lumig, P.

AU - Romeijn, G.L.E.

AU - Schuttelaar, M.L.

AU - de Bruin-Weller, M.S.

N1 - Funding Information: Patients included in this manuscript participated in the BioDay registry sponsored by Sanofi-Regeneron, Abbvie, Eli Lilly and Company, Leo Pharma, and Pfizer.

PY - 2023/1/1

Y1 - 2023/1/1

U2 - 10.1002/clt2.12219

DO - 10.1002/clt2.12219

M3 - Comment/Letter to the editor

C2 - 36705510

SN - 2045-7022

VL - 13

JO - Clinical and Translational Allergy

JF - Clinical and Translational Allergy

IS - 1

M1 - e12219

ER -